Symbiotec Pharmalab Ltd made a quiet but steady debut on the bourses today, listing on both BSE and NSE on 01 September 2026. The stock opened at its issue price of ₹988—a straight‑through performance that translated to a 0.0% listing day gain, indicating investors quickly aligned the valuation with their expectations.
There were no bulk deals reported on the listing day, underscoring the orderly nature of the transaction and suggesting a balanced participation from various investor categories. Symbiotec Pharmalab is a research‑driven, science‑based pharmaceutical and biotechnology company, with a strong global footprint in corticosteroid and steroidal hormone active pharmaceutical ingredients (APIs), built over more than three decades of industry expertise and operational scale across organic chemistry, biotechnology and complex injectables.([ipo360.in](https://www.ipo360.in/company/symbiotec-pharmalab-limited-ipo?utm_source=openai))
| Issue Price | ₹988 |
| Listing Price | ₹988 |
| Closing Price | – |
| Listing Day Gain | +0.0% |
No bulk deals were reported for Symbiotec Pharmalab Ltd on listing day.
See the full profile on the Symbiotec Pharmalab Ltd IPO page.
Listing and closing price figures are sourced from official exchange data feeds.